Entero Healthcare Board Meeting on Aug 7 to Approve Q1 FY27 Results

Entero Healthcare Solutions Ltd has announced that its Board of Directors will convene on August 7, 2026. The primary agenda item is to consider, approve, and take on record the Unaudited Standalone and Consolidated Financial Results for the first quarter ended June 30, 2026. A limited review report will also be presented. The company has also reminded stakeholders that the trading window for dealing in its securities remains closed for designated persons and their immediate relatives from July 1, 2026, until 48 hours after the results are declared.